Bilexa Inhalation Capsule is a fixed-dose combination inhalation medicine containing Vilanterol Trifenatate (25 mcg) and Fluticasone Furoate (100 mcg). It is formulated for the maintenance treatment of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD), where both bronchodilation and anti-inflammatory control are required. This combination helps improve lung function, control symptoms, and maintain long-term respiratory stability.

Vilanterol Trifenatate is a long-acting beta₂-agonist (LABA) that relaxes bronchial smooth muscles, resulting in prolonged bronchodilation and improved airflow. Fluticasone Furoate is a potent inhaled corticosteroid that reduces airway inflammation, swelling, and mucus secretion. Together, these two agents provide effective and sustained control of respiratory symptoms when used regularly.

Bilexa Inhalation Capsule is intended for inhalation use with a compatible dry powder inhaler device and is not suitable for the relief of acute breathing difficulties.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Benefits

Dual-Action Respiratory Control

• Combines a long-acting bronchodilator with an inhaled corticosteroid.

• Addresses both airway narrowing and underlying inflammation.

Improves Breathing & Lung Function

• Helps keep airways open for extended periods.

• Reduces breathlessness, wheezing, and chest tightness.

Maintains Long-Term Symptom Control

• Regular use helps reduce the frequency and severity of asthma and COPD exacerbations.

• Supports stable respiratory function over time.

Anti-Inflammatory Protection

• Fluticasone furoate reduces airway irritation and swelling.

• Helps control chronic inflammation associated with respiratory diseases.

Convenient Once-Daily Therapy

• Long duration of action allows once-daily dosing.

• Encourages better treatment adherence.

Indications

Bilexa Inhalation Capsule is indicated for:

• Maintenance treatment of asthma in patients who require combination therapy.

• Long-term management of COPD, including chronic bronchitis and emphysema.

• Patients whose symptoms are not adequately controlled with inhaled corticosteroids or bronchodilators alone.

Dosage & Administration

Use Bilexa Inhalation Capsule strictly as prescribed by a healthcare professional. The capsule is for inhalation only and must not be swallowed. It should be used with an appropriate dry powder inhaler device. For best results, use the medication regularly at the same time each day.

Patients are advised to rinse the mouth after inhalation to reduce the risk of throat irritation or oral fungal infection.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety & Precautions

• Not intended for immediate relief of acute asthma attacks or sudden bronchospasm.

• Use with caution in patients with cardiovascular disease, infections, or steroid sensitivity.

• Do not exceed the recommended dose.

• Consult a doctor before use during pregnancy or breastfeeding.

• Store in a cool, dry place away from heat and moisture.

• Keep out of reach of children.

Why Choose Bilexa Inhalation Capsule?

Bilexa Inhalation Capsule provides effective and sustained respiratory control through its proven combination of Vilanterol Trifenatate and Fluticasone Furoate. The 25 mcg + 100 mcg strength is suitable for patients requiring moderate-dose inhaled corticosteroid therapy along with long-acting bronchodilation. Its once-daily dosing supports convenience, adherence, and improved quality of life for individuals with chronic respiratory conditions.